Skip to main content
TipRanks
Go Ultimate75% OFF

James Scibetta Insider Profile

4 Followers

James Scibetta, Director at Matinas BioPharma, holds 649.96K shares in Matinas BioPharma (Ticker: MTNB), holds 31.64K shares in Aquestive Therapeutics (Ticker: AQST), holds 27.08K shares in Pacira Pharmaceuticals (Ticker: PCRX).

James Scibetta's Trading History

MTNB
Matinas BioPharma
Jun 24, 2021DirectorUninformative Buy―$584.96K
AQST
Aquestive Therapeutics
Aug 22, 2019DirectorInformative Buy86.87K$123.69K
PCRX
Pacira Pharmaceuticals
Jun 07, 2017PresidentInformative Sell85.17K$987.48K

You May Also Like

James Scibetta insider profile FAQ

What is the percentage of profitable transactions made by James Scibetta?
The percentage of profitable transactions made by James Scibetta is 67%.
What is the average return per transaction made by James Scibetta?
The average return per transaction made by James Scibetta is 17.50%.
What stocks does James Scibetta hold?
James Scibetta holds: MTNB, PCRX, AQST stocks.
What was James Scibetta's most profitable transaction?
James Scibetta’s most profitable transaction was an Informative Buy of AQST stock on August 22, 2019. The return on the trade was 103.20%.
What is James Scibetta's role in Matinas BioPharma?
James Scibetta's role in Matinas BioPharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.